| 000 | 01373 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511165005.0 | ||
| 264 | 0 | _c19750720 | |
| 008 | 197507s 0 0 eng d | ||
| 022 | _a0091-2700 | ||
| 024 | 7 |
_a10.1002/j.1552-4604.1975.tb01450.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClark, M L | |
| 245 | 0 | 0 |
_aLoxapine in newly admitted chronic schizophrenic patients. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _cApr 1975 |
||
| 300 |
_a286-94 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDibenzoxazepines _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLoxapine _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 |
_aTrifluoperazine _xtherapeutic use |
| 700 | 1 | _aParedes, A | |
| 700 | 1 | _aCostiloe, J P | |
| 700 | 1 | _aWood, F | |
| 700 | 1 | _aBarrett, A | |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 15 _gno. 4 Pt 1 _gp. 286-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/j.1552-4604.1975.tb01450.x _zAvailable from publisher's website |
| 999 |
_c1099947 _d1099947 |
||